Paolo Marino

ORCID: 0000-0002-8192-412X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiac Valve Diseases and Treatments
  • Coronary Interventions and Diagnostics
  • Cardiac pacing and defibrillation studies
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Structural Anomalies and Repair
  • Venous Thromboembolism Diagnosis and Management
  • Pulmonary Hypertension Research and Treatments
  • Inflammatory Biomarkers in Disease Prognosis
  • Cardiovascular Disease and Adiposity
  • Cardiomyopathy and Myosin Studies
  • Heart Failure Treatment and Management
  • Lipoproteins and Cardiovascular Health
  • Neurological disorders and treatments
  • Congenital Heart Disease Studies
  • Infective Endocarditis Diagnosis and Management
  • Cardiovascular Effects of Exercise
  • Vitamin D Research Studies
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiovascular Health and Disease Prevention

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
2014-2023

Guy's and St Thomas' NHS Foundation Trust
2016-2022

Washington Center
2022

St Thomas' Hospital
2018-2021

HealthUnlocked (United Kingdom)
2021

Azienda Ospedaliero Universitaria Maggiore della Carita
2011-2020

Azienda Ospedaliera G.Rummo
2019-2020

The Royal Free Hospital
2019

University College London
2019

Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia
2019

Diastolic heart failure (DHF) currently accounts for more than 50% of all patients. DHF is also referred to as with normal left ventricular (LV) ejection fraction (HFNEF) indicate that HFNEF could be a precursor reduced LVEF. Because improved cardiac imaging and because widespread clinical use plasma levels natriuretic peptides, diagnostic criteria needed updated. The diagnosis requires the following conditions satisfied: (i) signs or symptoms failure; (ii) mildly abnormal systolic LV...

10.1093/eurheartj/ehm037 article EN European Heart Journal 2007-04-11

Background: Current diagnosis of heart failure with preserved ejection fraction (HFpEF) is suboptimal. We tested the hypothesis that comprehensive machine learning (ML) left ventricular function at rest and exercise objectively captures differences between HFpEF healthy subjects. Methods Results: One hundred fifty-six subjects aged >60 years (72 HFpEF+33 for initial analyses; 24 hypertensive+27 breathless independent evaluation) underwent stress echocardiography, in MEDIA study (Metabolic...

10.1161/circimaging.117.007138 article EN Circulation Cardiovascular Imaging 2018-04-01

Abstract Background Vitamin D (25‐ OH D3) deficiency represents a rising social and economic problem in Western countries. has been recently reported to modulate inflammatory processes, endothelium smooth muscle cell proliferation even platelet function, thus potentially modulating atherothrombosis. Great interest addressed on its impact cardiovascular outcome, with contrasting results. The aim of current study was evaluate the relationship between 25‐ D3 extent coronary artery disease (CAD)...

10.1111/eci.12281 article EN European Journal of Clinical Investigation 2014-05-14

Calcific coronary lesions impose a rigid obstacle to optimal balloon and stent expansion the 20 30 atm limit that non-compliant (NC) balloons reach can be insufficient. The aim of our study was evaluate safety efficacy new dedicated super high-pressure NC (OPN NC®; SIS Medical AG, Winterthur, Switzerland).We retrospectively evaluated consecutive series 91 in which conventional at maximal pressure failed achieve an adequate post-dilatation luminal gain were therefore treated with OPN up 40...

10.4244/eijy15m06_04 article EN EuroIntervention 2016-06-01
Coming Soon ...